- Home
- HSBC vs ABT Comparison
HSBC vs ABT Comparison
Compare HSBC & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HSBC | ABT |
|---|---|---|
| Founded | 1865 | 1888 |
| Country | United Kingdom | United States |
| Employees | 209000 | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.4B | 152.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | HSBC | ABT |
|---|---|---|
| Price | $93.70 | $93.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 20 |
| Target Price | N/A | ★ $130.90 |
| AVG Volume (30 Days) | 1.7M | ★ 9.6M |
| Earning Date | 05-05-2026 | 04-16-2026 |
| Dividend Yield | ★ 4.18% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $14.95 | $10.75 |
| Revenue Next Year | $3.66 | $8.10 |
| P/E Ratio | ★ $94.79 | $152.64 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $59.92 | $81.97 |
| 52 Week High | $96.90 | $137.49 |
Technical Indicators
Market Signals| Indicator | HSBC | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 61.79 |
| Support Level | $88.26 | $86.02 |
| Resistance Level | $95.20 | $112.81 |
| Average True Range (ATR) | 1.38 | 2.26 |
| MACD | 0.10 | 0.59 |
| Stochastic Oscillator | 71.15 | 77.89 |
Price Performance
Historical ComparisonAbout HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and over 40 million customers worldwide. It operates in more than 50 countries with over 200,000 full-time staff. Hong Kong and the United Kingdom are its two largest markets. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.